Synergistic System for Gynecological Disease Prevention and Treatment
Legal Citation
Summary of the Inventive Concept
A novel system integrating Sarcodon aspratus extracts-based pharmaceutical composition with AI, IoT, blockchain, and wearable devices for personalized, data-driven prevention and treatment of gynecological diseases.
Background and Problem Solved
The original patent disclosed a pharmaceutical composition containing Sarcodon aspratus extracts for preventing or treating gynecological diseases. However, it lacked a comprehensive approach to monitoring and managing treatment outcomes. The present inventive concept addresses this limitation by combining the pharmaceutical composition with cutting-edge technologies to provide a more effective and personalized treatment system.
Detailed Description of the Inventive Concept
The system comprises a wearable device monitoring physiological parameters, a blockchain-based data storage system, and a pharmaceutical composition containing Sarcodon aspratus extracts. Machine learning algorithms analyze the monitored data to generate a personalized treatment plan, which is administered to the subject through the wearable device. The blockchain-based platform tracks and manages treatment outcomes, ensuring secure and transparent data storage. The IoT-enabled sensors optimize pharmaceutical composition dosing based on real-time physiological parameter monitoring.
Novelty and Inventive Step
The inventive concept's novelty lies in the synergistic integration of distinct technologies, including AI, IoT, blockchain, and wearable devices, with the pharmaceutical composition containing Sarcodon aspratus extracts. The inventive step resides in the creation of a comprehensive system that provides personalized, data-driven treatment of gynecological diseases, overcoming the limitations of the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include varying the type of wearable device, incorporating additional AI-powered analytics, or integrating with existing healthcare systems. Variations may also involve using different blockchain platforms or IoT-enabled sensors to optimize system performance.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare and pharmaceutical industries, particularly in the areas of personalized medicine, women's health, and disease prevention. The target market includes healthcare providers, pharmaceutical companies, and patients seeking innovative, data-driven treatment solutions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K36/07 |
| A | A61 | A61K9/0056 |
| A | A61 | A61P15/08 |
| A | A61 | A61K2236/333 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical biotechnology, specifically gynecological disease treatment technologies, involving pharmaceutical compositions, medical device integration, and health monitoring systems
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in biotechnology, pharmaceutical sciences, or biomedical engineering, possessing expertise in medical device design, data analytics, and pharmaceutical formulation techniques
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with pharmaceutical compositions represents a predictable evolution in personalized medicine. The combination of Sarcodon aspratus extracts with AI-driven monitoring systems follows established trends in precision healthcare. The technical variations represent incremental improvements using known technological integration strategies that would be apparent to a skilled practitioner in the field.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,586 |
|---|---|
| Title | Pharmaceutical composition for preventing or treating gynecological diseases containing Sarcodon aspratus extracts as active ingredient |